02/27/2025
11:39 AM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:01 AM | Vir Biotechnology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025
3:23 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
2:43 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:44 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:34 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:36 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:37 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:39 PM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2025
2:41 PM | O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
7:56 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for VIR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. |
02/24/2025
7:57 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:57 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:38 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
7:40 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025
6:11 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:50 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
5:41 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2025
5:49 PM | Sabatini Brent (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
6:51 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:03 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:22 PM | SATO VICKI L (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
6:50 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
12:36 PM | O'Byrne Jason (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:20 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:51 PM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2024
3:20 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:26 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
11:29 AM | STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
| Form SC 13G/A | |
10/02/2024
11:09 AM | Sabatini Brent (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/02/2024
11:07 AM | de Verneuil Vanina (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/10/2024
3:28 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
7:10 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:29 PM | Napolitano Janet (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:43 PM | Vir Biotechnology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2024
3:40 PM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
2:26 PM | SHARP PHILLIP A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
7:15 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
11:21 AM | Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:01 PM | PEREZ ROBERT J (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
5:04 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
A deadly mistake in my prediction… (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.  Here’s the full story for you. |
06/03/2024
11:15 AM | Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:16 AM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:17 AM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:18 AM | Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
10:57 AM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/03/2024
10:59 AM | Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:08 AM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:13 AM | Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:14 AM | NELSEN ROBERT (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
1:38 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
1:40 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
1:42 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
1:43 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:06 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:05 PM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/19/2024
7:40 AM | Vir Biotechnology (Filer)
| Form ARS | |
04/19/2024
7:32 AM | Vir Biotechnology (Filer)
| Form DEF 14A | |
04/19/2024
7:35 AM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/18/2024
7:44 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
3:14 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:58 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:18 AM | Lee Sung (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
